Searching over 5,500,000 cases.


searching
Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.

White v. Novartis Pharmaceuticals Corp.

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF CALIFORNIA


July 12, 2010

CHERYL J. WHITE, SUCCESSOR TO WILLIAM WHITE, PLAINTIFF,
v.
NOVARTIS PHARMACEUTICALS CORPORATION, DEFENDANT.

[PROPOSED] ORDER TO SEAL DOCUMENTS

Complaint Filed: March 29, 2006 Trial Date: November 16, 2010

The Court, having considered, pursuant to Civil Local Rule 141, the request by defendant Novartis Pharmaceuticals Corporation ("NPC") to seal certain exhibits (or parts of exhibits) upon which NPC relies in support of its July 7, 2010 Daubert motions, and for good cause shown, hereby grants NPC's request orders that the following documents be maintained under seal until further order of the Court:

A. Certain Exhibits to Declaration of Martin Calhoun in Support of NPC's Daubert Motion to Exclude Expert Testimony of Plaintiff's Expert Wayne Ray, Ph.D. (Docket No. 88)

Exhibit 5: Arrowsmith Expert Report. This document shall be maintained by the Court under seal.

Exhibit 9: Zometa(r) Periodic Safety Update Report 10. This document shall be maintained by the Court under seal.

Exhibit 16: Expert Report of Professor Wayne Ray. NPC filed this exhibit publicly with the exception of redacting sections 6.1.2 and 6.1.3. The unredacted copy of this document shall be maintained by the Court under seal.

Exhibit 17: Revised Expert Report of Professor Wayne Ray.NPC filed this exhibit publicly with the exception of redacting sections 6.1.2 and 6.1.3. The unredacted copy of this document shall be maintained by the Court under seal.

Exhibit 57: Revised Versions of Professor Ray's Figure 7 and Figure 8 as filed under seal in In re Aredia and Zometa Prods. Liab. Litig., 3:06-md-1760 in support of NPC's Daubert Mot. to Exclude Test. of Pl.'s Expert Wayne Ray, Ph.D. (M.D. Tenn. June 1, 2009) (MDL Docket No. 2386).This document shall be maintained by the Court under seal.

B. Certain Exhibits to Declaration of Martin Calhoun in Support of NPC's Daubert Motion to Exclude Expert Testimony of Plaintiff's Expert Robert Fletcher, M.D. (Docket No. 78)

Exhibit 3: J. Caminis et al., Maxillofacial Complication Adjudication Committee Charter (June 8, 2005). This document shall be maintained by the Court under seal.

Exhibit 4: John Grbic & Regina Landesberg, Special Expert Evaluation Report (SpEER) of Maxillofacial Adverse Events of 5 mg Zoledronic Acid Given Once Yearly(Jan. 3, 2007). This document shall be maintained by the Court under seal.

C. Certain Exhibits to Declaration of Martin Calhoun in Support of NPC's Daubert Motion to Exclude Expert Testimony of Plaintiff's Expert James Vogel, M.D. (Docket No. 70)

Exhibit 1: Vogel Expert Report. NPC shall publicly file this report with redactions of paragraphs 26, 36(f), 40, 51, and 60. The unredacted copy of this document shall be maintained by the Court under seal.

Exhibit 3: Transcript of the Deposition of Dr. James Vogel (Jan. 7, 2010). NPC seeks to seal pages 319-24 of this transcript. These pages will be maintained under seal by the Court. NPC shall publicly file the other pages of Exhibit 3.

D. Certain Exhibits to Declaration of Martin Calhoun in Support of NPC's Daubert Motion to Exclude Expert Testimony of Plaintiff's Expert Suzanne Parisian (Docket No. 83)

Exhibit 6: Expert Report of Dr. Suzanne Parisian. This document shall be maintained by the Court under seal.

Exhibit 9: Rebuttal Report of Dr. Suzanne Parisian. This document shall be maintained by the Court under seal.

Exhibit 13: Parisian Testimony Table. This document shall be maintained by the Court under seal.

E. Exhibit to Declaration of Martin Calhoun in Support of NPC's Daubert Motion to Exclude Causation Testimony of Plaintiff's Non-Retained Experts (Docket No. 94)

Exhibit 51: Expert Report of Nelson Rhodus. NPC shall publicly file all pages upon which it relied in support of this Daubert motion.

SO ORDERED:

Date: July 8, 2010

Respectfully submitted,

Martin C. Calhoun Katharine R. Latimer (admitted pro hac vice) (klatimer@hollingsworthllp.com)

Martin C. Calhoun (admitted pro hac vice) (mcalhoun@hollingsworthllp.com)

HOLLINGSWORTH LLP 1350 I Street, N.W. Washington, DC 20005 Telephone: (202) 898-5800 Facsimile: (202) 682-1639

James A. Bruen (State Bar No. 43880) (jbruen@fbm.com)

Sandra A. Edwards (State Bar No. 154578) (sedwards@fbm.com)

FARELLA BRAUN & MARTEL LLP 235 Montgomery Street, 17th Floor San Francisco, CA 94104 Telephone: (415) 954-4400 Facsimile: (415) 954-4480 Attorneys for Defendant Novartis Pharmaceuticals Corporation

20100712

© 1992-2010 VersusLaw Inc.



Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.